Key result
Cardioneuroablation targeting both sinus and atrioventricular node innervation successfully eliminated recurrent syncope over 9 months of follow-up in a patient with refractory vasovagal syncope.
Why the study?
Vasovagal syncope can cause reduced quality of life, but pacemaker implantation in younger patients poses a risk-to-benefit dilemma due to long-term device-related complications.
Case Report (n=1)
No
Cardioneuroablation for vasovagal syncope may result in isolated atrioventricular block, suggesting distinct innervation of the sinus and atrioventricular nodes.
Answers are grounded in this paper and cite their sources.
Requires post-procedure AV block monitoring; hypothesis-generating for distinct sinus and AV nodal innervation.
Vasovagal syncope (VVS) is a common and typically benign cause of transient loss of consciousness. Nevertheless, it can cause reduced quality of life and disability, prompting consideration of a pacemaker implant. In younger patients, pacemaker implantation creates a risk-to-benefit dilemma due to the risk of long-term exposure to potential device-related complications.1,2 First described by Pachon and colleagues in 2004, endocardial radiofrequency (RF) catheter ablation of the myocardial tissue adjacent to and containing the autonomic nerve fibers related to the intrinsic cardiac parasympathetic ganglionated plexi (GPs), termed cardioneuroablation (CNA), has been shown in observational cohorts to successfully reduce the burden of VVS in selected patients.
No takes yet. Share an insight, caveat, or question.
Maher et al. (2022) conducted a case report in Vasovagal syncope (n=1). Cardioneuroablation was evaluated on Syncope recurrence. Cardioneuroablation targeting both sinus and atrioventricular node innervation successfully eliminated recurrent syncope over 9 months of follow-up in a patient with refractory vasovagal syncope.
Synapse has enriched 10 related papers. Consider them for comparative context: